Papers
3
Total Citations
27
H-Index
3
About
Huiming Wu is a leading researcher in the field of minimally invasive surgical oncology, with a primary focus on the application of robotic-assisted technologies for the treatment of colorectal and gastric cancers. Dr. Wu’s major contributions center on evaluating and advancing robot-assisted laparoscopic surgery, particularly for mid and low rectal cancer, as demonstrated in their highly cited 2023 meta-analysis (15 citations), which systematically assessed both short-term and long-term therapeutic efficacy. This work provides critical evidence for the clinical benefits of robotic approaches. Further extending this impact, Dr. Wu has authored pioneering reviews on robot-assisted natural orifice specimen extraction surgery (NOSES) for colorectal cancer (2024, 9 citations), highlighting its potential to redefine minimally invasive standards. Most recently, their 2025 narrative review on ICG fluorescence imaging in robotic D2 lymphadenectomy for gastric cancer (3 citations) explores cutting-edge techniques to improve surgical precision and patient prognosis. Through these influential studies, Dr. Wu is shaping the future of surgical oncology by rigorously evaluating and promoting innovative, patient-centered robotic interventions.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3